Dr. Aijun Wang is a Chancellor's Fellow Professor of Surgery and of Biomedical Engineering at the University of California, Davis (UC Davis). He is the Vice Chair for Translational Research, Innovation and Entrepreneurship for the Department of Surgery, Co-Director of the Center for Surgical Bioengineering, and former Dean's Fellow in Entrepreneurship at the UC Davis School of Medicine. He is also a Principal Investigator at the Institute for Pediatric Regenerative Medicine (IPRM) / Shriners Children's Pediatric Research Center, Northern California.

Dr. Wang received his Ph.D. in biology from Tsinghua University, Beijing, China, and underwent postdoctoral training at the UC Berkeley Department of Bioengineering and Berkeley Stem Cell Center, with a postdoctoral fellowship from California Institute for Regenerative Medicine (CIRM). He has been a faculty member of UC Davis since 2012. 

Dr. Wang's research focuses on developing tools and technologies that combine molecular, cellular, tissue and biomaterial engineering to promote regeneration and restore function. The Wang Group engineers and develops stem cells, extracellular vesicles/nanomedicine and extracellular matrix/biomaterial scaffolds for the treatment of surgical conditions and diseases. The Wang Lab collaborates with the UC Davis Veterinary Medicine colleagues in developing naturally-occurring disease models to evaluate regenerative products for accelerated translational application and carry out clinical trials in companion animals. The Wang Lab also produces clinical-grade stem cell products, carries out investigational new drug (IND)-enabling studies required by the U.S. Food and Drug Administration (FDA) for clinical applications, and conducts clinical trials in human patients.

Dr. Wang has been serving as PI on several major grants supported by NIH/NIBIB, NIH/NICHD, NIH/NINDS, the California Institute for Regenerative Medicine (CIRM), the University of California Center for Accelerated Innovation (UC-CAI), the Tobacco-Related Disease Research Program of California (TRDRP), Shriners Hospital for Children and other foundations. Dr. Wang has filed more than 20 US and international patent applications, published over 170 peer-reviewed papers and has received numerous awards, such as the UC Davis Health Deans’ Fellowship (2018), UC Davis Health Deans’ Team Award for Excellence in Research (2020), UC Davis Chancellor's Fellowship (2020), UC Davis School of Medicine Cultivating Team Science Award (2022), Deloitte QB3 Award for Innovation (2012), the Tony Phillips Research Award (2014) from the Children’s Miracle Network (CMN), the Basil O’Connor Starter Scholar Research Award (2016) from the March of Dimes Foundation, the NIH/NHLBI Technology Development Award (2017), the KidneyX: Redesign Dialysis Phase 2 Innovation award (2020) from the American Society of Nephrology (ASN) and the Department of Health and Human Services (HHS), and the Sacramento Region Innovation Award (2021). Dr. Wang was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2024.